On March 21, 2022, Pier Vincenzo Piazza, CEO of Aelis Farma and Stéphanie Monlezun, COO, attended the first F2F ICOD symposium in Troina.
They were invited to present to families and associations the potential of AEF0217 as a new path for the treatment of cognitive impairments in Down syndrome.
Thank you so much to the ICOD consortium and special thanks to #FilippoCaraci and #OasiMariaTroina team for such an amazing World Down syndrome Day.
#WorldDownsyndromday #HorizonEU #EUresearch #biotech #cognitivedisorders